Ethyl 4-[(6-imidazol-1-ylimidazo[1,2-a]pyridin-2-yl)carbamoyl]benzoate | 1415658-69-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Ethyl 4-[(6-imidazol-1-ylimidazo[1,2-a]pyridin-2-yl)carbamoyl]benzoate
• 英文别名: ethyl 4-[(6-imidazol-1-ylimidazo[1,2-a]pyridin-2-yl)carbamoyl]benzoate
• CAS: 1415658-69-3
• 化学式: C₂₀H₁₇N₅O₃
• 分子量: 375.387
• InChiKey: OOTIRLKUODJOSJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  28
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  90.5
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  Ethyl 4-[(6-imidazol-1-ylimidazo[1,2-a]pyridin-2-yl)carbamoyl]benzoate 、 甲基溴化镁 以 四氢呋喃 为溶剂， 反应 3.0h， 生成 4-(1-hydroxy-1-methylethyl)-N-[6-(1H-imidazol-1-yl)imidazo[1,2-a]pyridin-2-yl]benzamide
  参考文献：
  名称：

  Design and biological evaluation of imidazo[1,2-a]pyridines as novel and potent ASK1 inhibitors

  摘要：

  Imidazo[1,2-a]pyridine derivatives were designed, synthesized, and evaluated as inhibitors of the apoptosis signal-regulating kinase 1 (ASK1). These were based on a benzothiazole derivative that was discovered from high-throughput screening of our compound library. As a result, we identified potent, selective, and orally bioavailable ASK1 inhibitors for wide range of therapeutic targets. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.10.084